Since reporting a profitable fiscal Q2 with $11.1 million in revenue, Bloom Health Partners (CSE: BLMH) has seen a share price increase of 110%.
Q2 results mark a 92.1% increase over fiscal Q1 revenue, bringing the company’s YTD revenues to $16.9 million. This puts $BLMH well on track to meet or even surpass its 2022 revenue guidance of $25-$28 million.
With the business growing rapidly, $BLMH.c has announced a private placement for $2 million. Funds will be put towards ongoing working capital and corporate development.
The company has proven its ability to successfully evolve into a premium provider of Operation Health and Health Tech solutions to Fortune 500 companies, film/TV productions and large organizations. This makes me really excited to watch Bloom’s growth over the next 2 quarters.
$BLMH.c is currently trading at $.25, valued at $9.73 million.
https://ceo.ca/@newsfile/bloom-health-partners-reports-profitable-fiscal-q2